Page last updated: 2024-09-03

gefitinib and Helicobacter Infections

gefitinib has been researched along with Helicobacter Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, Z; El-Rifai, W; Garcia-Buitrago, M; Khalafi, S; Lu, H; Peng, D; Poveda, J; Que, J; Soutto, M; Zaika, A; Zhu, S	1

Other Studies

1 other study(ies) available for gefitinib and Helicobacter Infections

Article	Year
Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib. Cancer letters, 2020, 10-28, Volume: 491 Topics: Animals; Cell Line, Tumor; DNA Methylation; Dopamine and cAMP-Regulated Phosphoprotein 32; Drug Resistance, Neoplasm; Gefitinib; Helicobacter Infections; Helicobacter pylori; Humans; Mice; Mice, Inbred C57BL; MicroRNAs; Receptor, Muscarinic M2; Stomach Neoplasms	2020

Article

Year

Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib.

Cancer letters, 2020, 10-28, Volume: 491

Topics: Animals; Cell Line, Tumor; DNA Methylation; Dopamine and cAMP-Regulated Phosphoprotein 32; Drug Resistance, Neoplasm; Gefitinib; Helicobacter Infections; Helicobacter pylori; Humans; Mice; Mice, Inbred C57BL; MicroRNAs; Receptor, Muscarinic M2; Stomach Neoplasms

2020